Mindfulness-Integrated Psychoeducation for Patients With Schizophrenia
NCT07917520, Not applicable, Completed, Menoufia University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mindfulness-Integrated Psychoeducation for Patients With Schizophrenia | ClinicalTrials.gov |
| NCT number | NCT07917520 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 60 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Menoufia University | ClinicalTrials.gov |
| Conditions | Schiphrenia | ClinicalTrials.gov |
| Interventions | Mindfulness-Integrated Psychoeducational Nursing Intervention | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Changes in Insight and Medication Adherence from baseline to 12 weeks after the intervention, measured using the Birchwood Insight Scale (BIS) and Morisky Medication Adherence Scale (MMAS-8) | Baseline and 12 weeks after the intervention | Insight and Medication Adherence will be assessed using the Birchwood Insight Scale (BIS) and Morisky Medication Adherence Scale (MMAS-8) . these scales are validated instruments used to assess clinical insight and adherence to prescribed psychiatric medications among patients with schizophrenia, respectively. Higher scores indicate better insight and medication adherence. Changes in scores from baseline to 12 weeks post-intervention will be analyzed. | ClinicalTrials.gov |
| Secondary | Change in Aggressive Behavior outcomes from baseline to 12 weeks after the intervention, measured using a validated the Buss-Perry Aggression Questionnaire | Baseline and 12 weeks after the intervention | Aggressive behaviors will be measured using the Buss-Perry Aggression Questionnaire (BPAQ), a validated instrument assessing different dimensions of aggression, including physical aggression, verbal aggression, anger, and hostility. Higher scores indicate greater levels of aggression. Changes from baseline to 12 weeks post-intervention will be evaluated. | ClinicalTrials.gov |
| Other | Change in Aggressive Behavior outcomes from baseline to 12 weeks after the intervention, measured using a validated the Buss-Perry Aggression Questionnaire | Baseline and 12 weeks after the intervention | Aggressive behaviors will be measured using the Buss-Perry Aggression Questionnaire (BPAQ), a validated instrument assessing different dimensions of aggression, including physical aggression, verbal aggression, anger, and hostility. Higher scores indicate greater levels of aggression. Changes from baseline to 12 weeks post-intervention will be evaluated. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)